- Official US price
- $93 / 15 mL
- Peptide
- Pal-GHK-Cu
- Base detail
- More than 50% squalane, per manufacturer
The lipid base is central to the concept
NIOD describes CAIL as a nighttime gel and lists its format as a balm. Its copper ingredient is an oil-friendly derivative identified as Copper Tripeptide-1 Palmitamide. Squalane makes up more than half of the formulation according to the page.[source]
Those details make it meaningfully different from a conventional emulsion cream. They also explain why comparing the product name’s 1% directly with another brand’s stated percentage is not a defensible potency ranking.
Hydration and appearance need their own time frames
The manufacturer reports tests involving 41 people, with some observations after one application and others after repeated use. A short-term change in apparent lines or softness is not the same finding as permanent tissue remodeling.[source]
We have not independently examined the full protocol or reproduced the results. There is no verified head-to-head comparison in this review showing CAIL is better than the other four selected products. Its stated methods are useful reading, with those limits intact.
A format preference with a clear container cost
The US listing shows a 15 mL container at $93. Actual duration depends on labeled use; we do not invent a monthly cost by assigning an application amount. Check current availability and purchase terms in the selected market.[source]
CAIL may appeal to someone specifically seeking a lipid-rich evening product. Readers should still compare the full ingredient list and any existing routine instructions. The absence of a prescription appointment does not establish suitability for every skin condition, and the product is not presented as a wound treatment or sunscreen.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- NIOD: Copper Amino Isolate Lipid 1%Official source; checked October 8, 2026